See What HealthDay Can Do For You
Contact Us

Coronary Collateral Flow Predicts Outcomes in STEMI

Extensive collateral networks associated with better survival, fewer adverse events

THURSDAY, Sept. 2 (HealthDay News) -- The extent of coronary collateral flow in ST-elevation myocardial infarction (STEMI) patients prior to mechanical reperfusion may predict their long-term clinical outcomes, according to research published in the Sept. 1 issue of the American Journal of Cardiology.

Steffen Desch, M.D., of the University of Leipzig Heart Center in Germany, and colleagues studied long-term outcomes in 227 STEMI patients undergoing percutaneous coronary intervention to examine the role of pre-reperfusion coronary collateral flow on long-term prognosis.

The researchers found the degree of collateral flow at baseline to be a predictor of long-term outcomes. During the median follow-up of 797 days, 22 (13.8 percent) of the 166 patients with absent or weak collateral flow died compared with three (4.4 percent) of the 69 patients who had significant flow (P = 0.04). In addition, 12 (7.5 percent) of those with absent or weak collateral flow experienced nonfatal recurrent myocardial infarctions, compared with two (2.9 percent) of the patients who had significant flow (P = 0.18). There was a significantly lower event rate for the combined major adverse cardiovascular event end point (death or nonfatal reinfarction) in the group with significant flow.

"In conclusion, the presence of a well-developed collateral network before mechanical reperfusion in patients with STEMI is associated with improved long-term survival and lower major adverse cardiovascular event rates," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.